First domino, named next dominoes: management generalizes a fresh win into a repeatable template and points to the speci
The model's full reasoning — Q1 2022 call → NOWe need to determine if management explicitly generalizes a recent real success as a repeatable template and identifies specific next places where it's being applied. The transcript covers OPKO's Q1 2022 earnings. Key topics: ModeX acquisition, BioReference Labs, COVID testing, Scarlet Health, etc. We need to find a specific success that management treats as a template and then names specific next applications. Look for phrases like "template", "repeat", "we can do this again", "we are applying this to", etc. In the transcript, Jon Cohen discusses BioReference's strategy. He mentions "our commercial payer interactions continue to be successful with our preferred status with Aetna, which became effective on the 1st of this year. Volume in our clinical base business increased 4% versus the fourth quarter, driven by our preferred status with UnitedHealthcare and Aetna." That's a success but not necessarily a template. He also talks about Scarlet Health, the at-home digital initiative. He says: "Scarlet services are now available in most of the Continental United States. We are receiving added reimbursement from payers as a specifically covered service for over 85 million patients through our national and regional plans. We are seeing significant demand for Scarlet across our different commercial verticals, including oncology, women's health, urology, and strategic ventures. We are also finding success with digital health clients, including telehealth, home health care, and virtual primary care networks as well as direct-to-consumer and patient initiative testing. I am proud to announce today a formal relationship with Teladoc, one of the largest providers of telehealth services in the country with over 14.7 million visits last year. Scarlet is now offered by Teladoc Health as part of their new whole person health care experience. We also announced a collaboration with MVP Healthcare to offer their members medically necessary COVID testing, routine blood work and other diagnostic tests in the comfort of their homes." This seems like a success: Scarlet is working, they have a relationship with Teladoc and MVP.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MCD | McDonald's Corporation | Q2 2024 | 2024-07-29 | D |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
T · Q3 2018 → YESThe question is: Does management take a RECENT, REAL SUCCESS and explicitly GENERALIZE it as a template they can repeat, AND identify SPECIFIC NEXT PLACES where that template is already being applied?...YES The transcript shows management treating the AdWorks success (22% revenue growth on a declining subscriber base) as a proven template for targeted advertising, then explicitly identifying the next applications: applying the same technology to Turner inventory and signing up additional distributors (Frontier and Altice) as concrete next repetitions already in motion. 5G and FirstNet do not qualify because their first instances are still prospective or ongoing without a completed, repeatable proof-of-concept.
LOW · Q3 2021 → YESThe question is about whether management takes a recent real success and generalizes it as a template they're applying to specific next places. YES The transcript shows management treating the market-based delivery model as a proven template after the first success in Florida and the second in Ohio Valley this quarter. They explicitly generalize it as a repeatable approach that is already driving measurable results (higher sales in appliances, improved margins, reduced inventory, higher on-time delivery) and plan 18+ months of rollout across the entire US.
FLR · Q2 2022 → YESThe question is about whether management takes a recent, real success and generalizes it as a template they can repeat, and identifies specific next places where it's being applied. YES The transcript shows management treating the LNG 1 project (awarded last quarter) as a proven template: David Constable states they have “proven that our mid-scale modular design and execution plans facilitates repeatable models that can be used to replicate and fast track similar LNG plants in the future.